Endometrial stromal sarcomas - A retrospective analysis of 11 patients

Anticancer Research

Volumn 26, Issue 1 B, 2006, Pages 655-661

  Diesing, Dagmar ^a   Cordes, T ^a   Finas, D ^a   Loning M ^a   Mayer, K ^b   Diedrich, K ^a   Friedrich, M ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Endometrial stromal sarcoma; Uterine sarcoma

Indexed keywords

AMINOGLUTETHIMIDE; AROMATASE INHIBITOR; GESTAGEN; LETROZOLE; MEGESTROL ACETATE; METHOTREXATE; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CURETTAGE; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM SARCOMA; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; STROMA CELL; SURVIVAL RATE; SYMPTOMATOLOGY; UTERUS SARCOMA; VAGINA BLEEDING;

ADULT; AGED; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PARITY; PREGNANCY; RETROSPECTIVE STUDIES; SARCOMA, ENDOMETRIAL STROMAL;

EID: 32144455417     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Wolf A and Vahrson H: Zur Prognose der Genitalsarkome bei der erwachsenen Frau. Geburtsh und Frauenheilk 36: 856-861, 1976.
2. Berchuck A, Saigo PE, Pierce VK and Lewis JL Jr: Treatment of endometrial stromal sarcoma. Gynecol Oncol 36: 60-65, 1990.
3. Clarke MR: Uterine malignant mixed Mullerian tumor in a patient on long-term taxoxifen therapy for breast cancer. Gynecol Oncol 51: 411-415, 1993.
4. Nordal RR and Thoresen SO: Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. Eur J Cancer 33: 907-911, 1997.
5. De Fusco PA, Gaffey TA, Malkasian GD Jr, Long HJ and Cha SS: Endometrial stromal sarcoma: review of Mayo Clinic experience, 1645-1980. Gynecol Oncol 35: 8-14, 1989.
6. Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A, Lissoni A, Losa G and Fanucchi A: Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 63: 247-253, 1996.
7. Olah KS, Dunn JA and Gee H: Leiomyosarcoma have a poorer prognosis than mixed mesodermal tumors when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterina sarcoma. Br J Obst Gyn 99: 590-594, 1992.
8. Marchese MJ, Liskow AS, Crum CP and Frick II HC: Uterine sarcomas: a clinicopathologic study, 1965-1981. Gynecol Oncol 18: 299-312, 1984.
9. Kahanpaa KV, Wahlstrom T, Nieminen U and Widhholm O: Sarcomas of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 67: 417-424, 1986.
10. Saksela E, Lampinen V and Procope BJ: Malignant mesenchymal tumors of the uterine corpus. Am J Obstet Gynecol 120: 452-460, 1974.
11. Piver MS and Lurain JR: Uterine sarcomas: Clinical features and management. In: Gynecologic Oncology. Fundamental Principles and Clinical Practice. Coppleson M (ed.), Churchill Livingstone, Edinburgh, Vol. 2: pp. 608-618, 1981.
12. Azoury R and Woodruff J: Primary ovarian sarcoms. Report of 43 cases from the Emil Novak Ovarian Tumor Registry. Obstet Gynec 37: 920, 1971.
13. Evans HL: Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50: 2170-2182, 1982.
14. Oliva E, Clement P and Young R: Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol 7: 257-281, 2000.
15. Amant F, Moerman P and Vergote I: The classification of a uterine sarcoma as 'High-grade endometrial stromal sarcoma' should be abandoned. Gynecol Oncol 95: 412-413, 2004.
16. Brooks SE, Zhan M, Cote T and Baquet CR: Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 93: 204-208, 2004.
17. Sutton GP, Frederick B, Stehman B and Ehrlich CE: Estrogen and progesterone receptors in uterine sarcomas. Obstet Gynecol 68: 709-714, 1986.
18. Katz L, Merino JJ, Sakamoto H and Schwartz PE: Endometrial stromal neoplasm: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors. Gynecol Oncol 26: 87-97, 1987.
19. Reich O, Regauer S, Urdl W, Lahousen M and Winter R: Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 82: 1030-1034, 2000.
20. Balleine RL, Earls PJ, Webster LR, Mote PA, deFazio A, Harnett PR and Clarke CL: Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma. Int J Gynecol Pathol 23: 138-144, 2004.
21. Navarro D, Cabrera JJ, Leon L, Chirino R, Fernandez L, Lopez A, Rivero JF, Fernandez P, Falcon O, Jimenez P et al: Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness. J Steroid Biochem Mol Biol 41: 589-596, 1992.
22. Amant F, Vloeberghs V, Woestenborghs H, Debiec-Rychter M, Verbist L, Moerman P and Vergote I: ERBB-2 gene overexpression and amplification in uterine sarcomas. Gynecol Oncol 95: 583-587, 2004.
23. Rush DS, Tan J, Baergen RN and Soslow RA: h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 25: 253-258, 2001.
24. Farhood AI and Abrams J: Immunohistochemistry of endometrial stromal sarcoma. Hum Pathol 22: 224-230, 1991.
25. Lifschitz-Mercer B, Czernobilsky B, Dgani R, Dallenbach-Hellweg G, Moll R and Franke WW: Immunocytochemical study of an endometrial diffuse clear cell stromal sarcoma and other endometrial stromal sarcomas. Cancer 59: 1494-1499, 1987.
26. Zhu XQ, Shi YF, Cheng XD, Zhao CL and Wu YZ: Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma. Gynecol Oncol 92: 71-79, 2004.
27. Agoff SN, Grieco VS, Garcia R and Gown AM: Immunohistochemical distinction of endometrial stromal sarcoma and cellular leimoyoma. Appl Immunohistochem Mol Morphol 9: 164-169, 2001.
28. McCluggage WG, Sumathi VP and Maxwell P: CD10 is a sensitive and diagnostically useful immunohistochemical marker of nomal endometrial stroma and of endometrial stromal neoplasms. Histopathology 39: 273-278, 2001.
29. Liokumovich P, Goldberg I, Davidson B, Gotlieb WH, Zahavi T, Ben-Baruch G, Reder I and Kopolovic J: Expression of metalloproteinases in endometrial stromal sarcoma: immunohistochemical study using image analysis. J Clin Pathol 52: 198-202, 1999.
30. Young RH, Prat J and Scully RE: Endometroid stromal sarcomas of the ovary. A clinicopathologic analysis of 23 cases. Cancer 53: 1143-1155, 1984.
31. Livi L, Andreopoulou E, Shah N, Paiar F, Blake P, Judson I and Harmer C: Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998. Clin Oncol (R Coll Radiol) 16: 261-268, 2004.
32. Benoit L, Arnould L, Cheynel N, Goui S, Collin F, Fraisse J and Cuisenier J: The role of surgery and treatment trends in uterine sarcoma. Eur J Surg Oncol 31: 434-442, 2005.
33. Calais G, Frinot-Rousseau S, Body G, Fetissoff F, Le Floch O and Lansac J: Sarcoma of the endometrium. Epidemiology and prognostic factors. Apropos of a study of 22 cases. J Gynecol Obstet Biol Reprod (Paris) 18: 885-889, 1989.
34. Haberal A, Kayikcioglu F, Boran N, Caliskan E, Ozgul N and Kose MF: Endometrial stromal sarcoma of the uterus: analysis of 25 patients. Eur J Obstet Gynecol Reprod Biol 709: 209-213, 2003.
35. Oliva E, Young RH, Clement PR and Scully RE: Myxoid and fibrous endometrial stromal tumors of the uterus: a report of 10 cases. Int J Gynecol Pathol 18: 310-319, 1999.
36. Wheelock JB, Krebs HB and Goplerud DR: Uterine sarcomas: 71 cases. Am J Obstet Gynecol 151: 1016-1022, 1985.
37. George M, Gyn. Coop. Group of French Oncol. Cent. Uterine sarcomas: prognostic factors and treatment modalities - study on 209 patients. Gynecol Oncol 24: 58-67, 1986.
38. Jereczek B, Jassem J and Kobierska A: Sarcoma of the uterus. Arch Gynecol Obstet 258: 171-180, 1995.
39. Weitmann HD, Knocke TH, Kucera H and Potter R: Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys 49: 739-748, 2001.
40. Geas FL, Tewari DS, Rutgers JK, Tewari KS and Berman ML: Surgical cytoreduction and hormone therapy of an advanced endometrial stromal sarcoma of the ovary. Ostet Gynecol 103: 1051-1054, 2004.
41. Bronz L, Genton DY, Kunz J and Schreiner WE: Purely mesenchymal homologous uterus sarcomas (leiomyosarcomas and endometrial stroma sarcomas) at the Zurich University Gynecologic Hospital. Geburtshilfe Frauenheilkd 45: 288-293, 1985.
42. Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL and Hendrickson MR: Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 14: 415-438, 1990.
43. El Husseiny G, Al Bareedy N, Mourad WA, Mohamed G, Shoukri M, Subhi J and Ezzat A: Prognostic factors and treatment modalities in uterine sarcoma. Am J Clin Oncol 25: 256-260, 2002.
44. Huang KT, Chen CA, Tseng GC, Chen TM, Cheng WF and Hsieh CY: Endometrial stromal sarcoma of twenty cases. Acta Obstet Gynecol Scand 75: 551-555, 1996.
45. Echt G, Jepson J, Steel J, Langholz B, Luxton G, Hernandez W, Astrahan M and Petrovich Z: Treatment of uterine sarcomas. Cancer 66: 35-39, 1990.
46. Tinkler SD and Cowie VJ: Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992. Br J Radiol 66: 998-1001, 1993.
47. Rose PG, Piver SM, Tsukada Y and Lau T: Patterns of metastasis in uterine sarcoma. An autopsy study. Cancer 63: 935-938, 1989.
48. Riopel J, Plante M, Renaud MC, Roy M and Tetu B: Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol Oncol 96: 402-406, 2005.
49. Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF and Boente MP: Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol 95: 632-636, 2004.
50. Weitmann HD, Kucera H, Knocke TH and Potter R: Surgery and adjuvant radiation therapy of endometrial stromal sarcoma. Wien Klin Wochenschr 114: 44-49, 2002.
51. Mansi JL, Ramachandra S, Wiltshaw E and Fisher C: Endometrial stromal sarcomas. Gynecol Oncol 36: 113-118, 1990.
52. Soumarova R, Horova H, Seneklova Z, Ruzickova J, Horova I, Budikova M, Slampa P and Kalabova R: Treatment of uterine sarcoma. A survey of 49 patients. Arch Gynecol Obstet 266: 92-95, 2002.
53. Vongtama V, Karlen JR, Piver SM, Tsukada Y and Moore RH: Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri. Am J Roentgenol 726: 139-147, 1976.
54. Livi L, Paiar F, Shah N, Blake P, Villanucci A, Amunni G, Barca R, Judson I, Lodge N, Meldolesi E, Simontacchi G, Piperno G, Galardi A, Scoccianti S, Biti GP and Harmer C: Uterine sarcoma: twenty-seven years of experience. Int J Radiat Oncol Biol Phys 57: 1366-1373, 2003.
55. Leunen M, Breugelmans M, De Sutter P, Bourgain C and Amy JJ: Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol 95: 769-771, 2004.
56. Reich O, Nogales FF and Regauer S: Gonadotropin-releasing hormone receptor expression in endometrial stromal sarcomas: an immunohistochemical study. Modern Pathol 18: 573-576, 2005.
57. Burke C and Hickey K: Treatment of endometrial stromal sarcoma with gonadotropin-releasing hormone analogue. Obstet Gynecol 104: 1182-1184, 2004.
58. Paillocher N, Lortholary A, Abadie-Lacourtoisie S, Morand C, Verriele V, Catala L and Descamps P: Low grade endometrial stromal sarcoma: contribution of hormone therapy and etoposide. J Gynecol Obstet Biol Reprod (Paris) 34: 41-46, 2005.
59. Scribner DR Jr and Walker JL: Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace. Gynecol Oncol 71: 458-460, 1998.
60. Maluf FC, Sabbatini P, Schwartz L, Xia J and Aghajanian C: Endometrial stromal sarcoma: objective response to letrozole. Gynecol Oncol 82: 384-388, 2001.
61. Spano JP, Soria JC, Kambouchner M, Piperno-Neuman S, Morin F, Morere JF, Martin A and Breau JL: Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 20: 87-93, 2003.
62. Salazar OM, Bonfiglio TA, Dunne ME and Rudolph J: Uterine sarcomas. Natural history, treatment and prognosis. Cancer 42: 1152-1160, 1978.
63. Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Mayerhofer S, Czerwenka K, Leodolter S, Kainz C and Mayerhofer K: Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 81: 160-165, 2001.
64. Covens AL, Nisker JA and Allen HH: Uterine sarcoma: an analysis of 74 cases. Am J Obstet Gynecol 156: 370-374, 1987.
65. Reich O and Regauer S: Endometrial stromal sarcoma - observational evidence of a genetic background? Eur J Gynaec Oncol 26: 288-290, 2005.